FR2205571A1 - Viral disease diagnosis - with antigen from incubated erythrocytes - Google Patents

Viral disease diagnosis - with antigen from incubated erythrocytes

Info

Publication number
FR2205571A1
FR2205571A1 FR7239741A FR7239741A FR2205571A1 FR 2205571 A1 FR2205571 A1 FR 2205571A1 FR 7239741 A FR7239741 A FR 7239741A FR 7239741 A FR7239741 A FR 7239741A FR 2205571 A1 FR2205571 A1 FR 2205571A1
Authority
FR
France
Prior art keywords
antigen
erythrocytes
incubated
viral disease
disease diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7239741A
Other languages
English (en)
French (fr)
Other versions
FR2205571B1 (OSRAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beckman Coulter Inc
Original Assignee
Beckman Instruments Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beckman Instruments Inc filed Critical Beckman Instruments Inc
Priority to FR7239741A priority Critical patent/FR2205571A1/fr
Publication of FR2205571A1 publication Critical patent/FR2205571A1/fr
Application granted granted Critical
Publication of FR2205571B1 publication Critical patent/FR2205571B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR7239741A 1972-11-09 1972-11-09 Viral disease diagnosis - with antigen from incubated erythrocytes Granted FR2205571A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7239741A FR2205571A1 (en) 1972-11-09 1972-11-09 Viral disease diagnosis - with antigen from incubated erythrocytes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7239741A FR2205571A1 (en) 1972-11-09 1972-11-09 Viral disease diagnosis - with antigen from incubated erythrocytes

Publications (2)

Publication Number Publication Date
FR2205571A1 true FR2205571A1 (en) 1974-05-31
FR2205571B1 FR2205571B1 (OSRAM) 1975-11-07

Family

ID=9106906

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7239741A Granted FR2205571A1 (en) 1972-11-09 1972-11-09 Viral disease diagnosis - with antigen from incubated erythrocytes

Country Status (1)

Country Link
FR (1) FR2205571A1 (OSRAM)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Also Published As

Publication number Publication date
FR2205571B1 (OSRAM) 1975-11-07

Similar Documents

Publication Publication Date Title
SE8701900D0 (sv) Pulsed drug delivery
SE8206168D0 (sv) Preparations and process for preparation thereof
BE596810A (fr) Tissus d'échange d'ions.
FR2601679B1 (fr) Immunotoxines, procede de preparation et compositions pharmaceutiques en contenant
FR2205571A1 (en) Viral disease diagnosis - with antigen from incubated erythrocytes
FI870297A0 (fi) Foerfarande foer skyddande av trae.
FR2332472A1 (fr) Soupape, notamment soupape d'entree d'air pour les pieces de sejour
FR2577048B1 (fr) Reactif pour le dosage par hemagglutination des anticorps contre les toxines bacteriennes, procede de preparation et son application
JPS5756426A (en) Novel salt and manufacture
SU639409A3 (ru) Фугицидный состав
ES2058931T3 (es) Un reactivo para la deteccion de actividad fibrinolitica.
SE7610167L (sv) Biocidalt aktiva foreningar
FI870623A0 (fi) Salt av ett substituerat morfolin och fluorborsyra samt traeskyddsmedel.
ES454866A1 (es) Metodo y sistema para determinar el titulo antiestreptolisi-nico de la sangre.
SE7613025L (sv) Stabila oxidasreagenslosningar
ES325472A1 (es) Procedimiento para la obtencion de de-amino-phe-arg-vasopresina.
ES2005159A6 (es) Procedimiento para diagnostico y seguimiento de hepatopatias mediante determinacion de factor de crecimiento hepatico en plasma yno suero sanguineo.
Bona et al. Ability of leucocytes to recognize some foreign gamma globulins during pinocytosis
FI922710A0 (fi) Eliminering av aktiverade lymfocyter.
GB1498295A (en) Treatment of dehydration in veterinary medicine
GB2021416A (en) Pest control
FR1118M (fr) La catalase, son introduction en thérapeutique humaine comme accélérateur de la fibrogenese.
FR1489M (fr) Diphénlysulfones substituées en 4,4' et leurs préparations pharmaceutiques pour le traitement des maladies virales.
FR1281M (fr) Nouveau médicament constitué par l'acide α(3-acétylamino-2,4,6-tri-iodo-phénoxy)-caproique, ou ses sels.
SE7707408L (sv) Ketenimincefalosporiner

Legal Events

Date Code Title Description
ST Notification of lapse